Jiang Yu

发表

Discovery and biological evaluation of darolutamide derivatives as inhibitors and down-regulators of wild-type AR and the mutants.

Xinghai Li, Mingxing Hu, J. Yu, 2019, European journal of medicinal chemistry.

Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma.

G. Sonpavde, H. Weiss, S. Lerner, 2007, Urology.

Expression of estrogen receptors‐α and ‐β in bladder cancer cell lines and human bladder tumor tissue

G. Sonpavde, S. Lerner, Carolyn L. Smith, 2006 .

Discovery and biological evaluation of novel androgen receptor antagonist for castration-resistant prostate cancer.

J. Yu, Xinghai Li, Guoyi Yan, 2019, European journal of medicinal chemistry.

Synthesis and evaluation of novel thiazole‐based derivatives as selective inhibitors of DNA‐binding domain of the androgen receptor

J. Yu, Lifeng Zhao, Ruixue Xu, 2018, Chemical biology & drug design.

Metabolically Stable Diphenylamine Derivatives Suppress Androgen Receptor and BET Protein in Prostate Cancer.

Xinghai Li, J. Yu, Guoyi Yan, 2020, Biochemical pharmacology.

735: Differential Expression of Estrogen Receptor α and β in Bladder Cancer Cell Lines and Human Bladder Tumor Tissue

G. Sonpavde, S. Lerner, Carolyn L. Smith, 2004 .

Novel therapeutic approach for bladder cancer: Synergistic effects with combined radiation and suicide gene therapy using a chimeric adenovirus vector

E. B. Butler, A. Davis, S. Lerner, 2004 .

Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.

G. Sonpavde, S. Lerner, Carolyn L. Smith, 2006, Cancer.

Effects of the histone deacetylase inhibitor FK228 in improving adenoviral mediated gene expression and suicide gene therapy inhumanTCC-sup bladder cancer

S. Lerner, W. Jian, Ling-Hao Li, 2004 .

From Castration‐Induced Apoptosis of Prostatic Epithelium to the Use of Apoptotic Genes in the Treatment of Prostate Cancer

Ye Zhang, J. Yu, B. Nan, 2002, Annals of the New York Academy of Sciences.

Monogene and polygene therapy for the treatment of experimental prostate cancers by use of apoptotic genes bax and bad driven by the prostate-specific promoter ARR(2)PB.

Ye Zhang, J. Yu, B. Nan, 2002, Human gene therapy.

Development of selective mono or dual PROTAC degrader probe of CDK isoforms.

Jijun Cheng, Yongmei Xie, Lifeng Zhao, 2019, European journal of medicinal chemistry.

Novel thiohydantoin analogues bearing the 1-hydroxyl-2,2,2-trifluoro-1-ethyl moiety as androgen receptor inhibitors for the potential treatment of castration resistant prostate cancer

Lifeng Zhao, Fan Lei, J. Yu, 2017 .

Design, synthesis and biological evaluation of deuterated Vismodegib for improving pharmacokinetic properties.

Lifeng Zhao, Yufang Deng, Yuanwei Chen, 2018, Bioorganic & medicinal chemistry letters.